Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Keratitis | 10 | 2026 | 56 | 3.700 |
Why?
|
| Eye Infections, Fungal | 7 | 2026 | 38 | 3.460 |
Why?
|
| Diaphragm | 4 | 2025 | 102 | 3.110 |
Why?
|
| Respiration, Artificial | 4 | 2025 | 486 | 2.230 |
Why?
|
| Rose Bengal | 12 | 2026 | 15 | 2.100 |
Why?
|
| Photochemotherapy | 11 | 2026 | 38 | 2.020 |
Why?
|
| Electromyography | 2 | 2025 | 136 | 1.790 |
Why?
|
| Photosensitizing Agents | 9 | 2026 | 34 | 1.760 |
Why?
|
| Airway Extubation | 2 | 2025 | 70 | 1.530 |
Why?
|
| Corneal Ulcer | 4 | 2023 | 28 | 1.500 |
Why?
|
| Ventilator Weaning | 3 | 2025 | 30 | 1.350 |
Why?
|
| Anti-Infective Agents | 6 | 2024 | 260 | 1.340 |
Why?
|
| Antifungal Agents | 4 | 2026 | 290 | 1.290 |
Why?
|
| Fusarium | 4 | 2026 | 10 | 1.240 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2025 | 121 | 1.110 |
Why?
|
| Riboflavin | 5 | 2023 | 28 | 1.070 |
Why?
|
| Byssochlamys | 1 | 2024 | 1 | 0.860 |
Why?
|
| Scedosporium | 1 | 2024 | 6 | 0.860 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2023 | 16 | 0.800 |
Why?
|
| Electrocardiography | 2 | 2025 | 918 | 0.770 |
Why?
|
| Visual Acuity | 1 | 2025 | 489 | 0.760 |
Why?
|
| Mycoses | 1 | 2023 | 102 | 0.750 |
Why?
|
| Corneal Diseases | 1 | 2023 | 78 | 0.740 |
Why?
|
| Collagen | 3 | 2023 | 293 | 0.720 |
Why?
|
| Cornea | 3 | 2023 | 496 | 0.610 |
Why?
|
| Cataract | 1 | 2019 | 143 | 0.560 |
Why?
|
| Fusariosis | 3 | 2026 | 5 | 0.530 |
Why?
|
| Lenses, Intraocular | 1 | 2019 | 206 | 0.530 |
Why?
|
| Ophthalmology | 1 | 2019 | 171 | 0.510 |
Why?
|
| Quality of Life | 1 | 2025 | 2023 | 0.470 |
Why?
|
| Iontophoresis | 1 | 2014 | 6 | 0.440 |
Why?
|
| Keratoconus | 1 | 2014 | 44 | 0.420 |
Why?
|
| Fungi | 1 | 2014 | 58 | 0.420 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2025 | 170 | 0.350 |
Why?
|
| Microscopy, Confocal | 3 | 2024 | 360 | 0.330 |
Why?
|
| Natamycin | 2 | 2026 | 4 | 0.300 |
Why?
|
| Amphotericin B | 2 | 2026 | 87 | 0.290 |
Why?
|
| Humans | 22 | 2026 | 126084 | 0.290 |
Why?
|
| Cross-Linking Reagents | 2 | 2021 | 50 | 0.280 |
Why?
|
| Aspergillus | 1 | 2026 | 24 | 0.240 |
Why?
|
| Entropy | 1 | 2025 | 27 | 0.230 |
Why?
|
| Scleritis | 1 | 2025 | 9 | 0.230 |
Why?
|
| Aged | 6 | 2025 | 20004 | 0.230 |
Why?
|
| Middle Aged | 8 | 2025 | 27329 | 0.230 |
Why?
|
| Pseudomonas Infections | 1 | 2025 | 109 | 0.210 |
Why?
|
| Salivary Glands, Minor | 1 | 2023 | 9 | 0.200 |
Why?
|
| Ulcer | 1 | 2023 | 49 | 0.200 |
Why?
|
| Mucous Membrane | 1 | 2023 | 86 | 0.200 |
Why?
|
| Respiratory Rate | 1 | 2022 | 7 | 0.190 |
Why?
|
| Steroids | 1 | 2023 | 157 | 0.190 |
Why?
|
| Nocardia | 1 | 2022 | 8 | 0.180 |
Why?
|
| Machine Learning | 1 | 2025 | 320 | 0.180 |
Why?
|
| Respiratory System | 1 | 2022 | 94 | 0.180 |
Why?
|
| Fluorescent Dyes | 2 | 2021 | 245 | 0.180 |
Why?
|
| Prostheses and Implants | 1 | 2023 | 144 | 0.180 |
Why?
|
| Male | 8 | 2025 | 62087 | 0.180 |
Why?
|
| Prosthesis Implantation | 1 | 2023 | 151 | 0.180 |
Why?
|
| Thorax | 1 | 2021 | 69 | 0.180 |
Why?
|
| Vision Disorders | 1 | 2023 | 188 | 0.170 |
Why?
|
| Eye Infections, Bacterial | 1 | 2021 | 53 | 0.170 |
Why?
|
| Pilot Projects | 4 | 2021 | 1386 | 0.170 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2026 | 810 | 0.170 |
Why?
|
| Eye Infections | 1 | 2019 | 2 | 0.160 |
Why?
|
| Female | 10 | 2025 | 67913 | 0.150 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2019 | 33 | 0.150 |
Why?
|
| Visual Field Tests | 1 | 2019 | 49 | 0.150 |
Why?
|
| Smartphone | 1 | 2019 | 44 | 0.150 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2019 | 17 | 0.150 |
Why?
|
| Spironolactone | 1 | 2019 | 22 | 0.150 |
Why?
|
| Intraocular Pressure | 1 | 2019 | 120 | 0.150 |
Why?
|
| Choroidal Neovascularization | 1 | 2019 | 20 | 0.150 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2019 | 43 | 0.150 |
Why?
|
| Algorithms | 1 | 2025 | 1619 | 0.150 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1096 | 0.150 |
Why?
|
| Bioreactors | 1 | 2018 | 43 | 0.140 |
Why?
|
| Visual Fields | 1 | 2019 | 132 | 0.140 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2019 | 106 | 0.140 |
Why?
|
| Light | 2 | 2019 | 163 | 0.140 |
Why?
|
| Macular Degeneration | 1 | 2019 | 89 | 0.140 |
Why?
|
| Follow-Up Studies | 1 | 2025 | 5050 | 0.120 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 3905 | 0.120 |
Why?
|
| Rats, Inbred Lew | 1 | 2014 | 64 | 0.110 |
Why?
|
| Aspergillus fumigatus | 1 | 2014 | 43 | 0.110 |
Why?
|
| Candida albicans | 1 | 2014 | 68 | 0.100 |
Why?
|
| Bacteriological Techniques | 1 | 2014 | 84 | 0.100 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2016 | 230 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 205 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 2 | 2025 | 2495 | 0.100 |
Why?
|
| Staphylococcal Infections | 1 | 2016 | 556 | 0.090 |
Why?
|
| Adult | 3 | 2025 | 30253 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 4409 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2019 | 12325 | 0.070 |
Why?
|
| Rats | 1 | 2014 | 3387 | 0.070 |
Why?
|
| Ultraviolet Rays | 2 | 2019 | 191 | 0.070 |
Why?
|
| Animals | 5 | 2022 | 33119 | 0.060 |
Why?
|
| Voriconazole | 1 | 2026 | 30 | 0.060 |
Why?
|
| Gels | 1 | 2023 | 69 | 0.050 |
Why?
|
| Florida | 1 | 2022 | 70 | 0.050 |
Why?
|
| Sheep | 1 | 2022 | 225 | 0.040 |
Why?
|
| Regeneration | 1 | 2023 | 205 | 0.040 |
Why?
|
| Rabbits | 1 | 2021 | 612 | 0.040 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2019 | 33 | 0.040 |
Why?
|
| Ophthalmic Solutions | 1 | 2019 | 72 | 0.040 |
Why?
|
| Euryarchaeota | 1 | 2018 | 2 | 0.040 |
Why?
|
| Biological Oxygen Demand Analysis | 1 | 2018 | 4 | 0.040 |
Why?
|
| Ranibizumab | 1 | 2019 | 11 | 0.040 |
Why?
|
| Anaerobiosis | 1 | 2018 | 14 | 0.040 |
Why?
|
| Bacteria, Anaerobic | 1 | 2018 | 8 | 0.040 |
Why?
|
| Manure | 1 | 2018 | 6 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2019 | 38 | 0.040 |
Why?
|
| Chemical Phenomena | 1 | 2018 | 81 | 0.040 |
Why?
|
| Methane | 1 | 2018 | 18 | 0.040 |
Why?
|
| Choroid | 1 | 2019 | 23 | 0.040 |
Why?
|
| Intravitreal Injections | 1 | 2019 | 39 | 0.040 |
Why?
|
| Microspheres | 1 | 2019 | 68 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2019 | 51 | 0.040 |
Why?
|
| Rats, Long-Evans | 1 | 2019 | 98 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2018 | 41 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6551 | 0.030 |
Why?
|
| Equipment Design | 1 | 2019 | 575 | 0.030 |
Why?
|
| Cattle | 1 | 2018 | 536 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 330 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2021 | 438 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2019 | 678 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2025 | 16768 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1485 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 2311 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 6093 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 9616 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 17584 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 19935 | 0.010 |
Why?
|